Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetically engineered yeast cells and their applications

D Pompon1, A Perret, A Bellamine

  • 1Centre de Génétique Moléculaire du CNRS, UPR 2420, Gifu-sur-Yvette, France.

Toxicology Letters
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world safety and effectiveness of neoadjuvant chemotherapy combination with pembrolizumab in triple-negative breast cancer.

ESMO real world data and digital oncology·2026
Same author

Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study.

ESMO open·2024
Same author

3D bioprinting for orthopaedic applications: Current advances, challenges and regulatory considerations.

Bioprinting (Amsterdam, Netherlands)·2021
Same author

The fox tapeworm, <i>Echinococcus multilocularis</i>, in grey wolves and dogs in Slovakia: epidemiology and genetic analysis.

Journal of helminthology·2020
Same author

Is intra-arterial hepatic chemotherapy painful?

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2020
Same author

Thermal radiation in Rayleigh-Bénard convection experiments.

Physical review. E·2020
Same journal

hERG Channel Blockade and Additive Interactions of Magnolol and Honokiol from Magnolia Species.

Toxicology letters·2026
Same journal

Evaluation of Dose-Dependent Hematotoxic Effects of Celastrol on Human Blood Cells In Vitro.

Toxicology letters·2026
Same journal

Environmental Pharmaceutical and Antibiotic Mixtures: An Exposomics-Guided Framework for Mechanistic Toxicology.

Toxicology letters·2026
Same journal

Size- and morphology-dependent cytotoxicity of metal-organic frameworks: Deciphering the structure-toxicity relationship.

Toxicology letters·2026
Same journal

Steroidogenesis suppression in H295R cells by 1,3-disubstituted ureas: A potential off-target effect of some sEH inhibitors.

Toxicology letters·2026
Same journal

Signaling pathways in tobacco smoking-induced cervical carcinogenesis: Beyond HPV-mediated activation.

Toxicology letters·2026
See all related articles

Engineered yeast expression systems have evolved through three generations, significantly enhancing human P450 enzyme activity for metabolic studies. This advancement aids in understanding complex pollutant metabolism, like benzo[a]pyrene, through yeast expression and computer simulations.

Area of Science:

  • Biotechnology
  • Enzyme Engineering
  • Metabolic Engineering

Background:

  • Early yeast expression systems used multicopy plasmids for human P450 production, relying on endogenous yeast reductase.
  • Second-generation systems improved P450 activity by overexpressing yeast reductase and co-expressing human cytochrome b5 and phase II enzymes.
  • These advancements allowed for better P450 turnover and simulation of phase I-phase II enzyme couplings.

Purpose of the Study:

  • To detail the evolution of yeast expression systems for enhanced human P450 activity.
  • To introduce a third-generation system replacing yeast reductase with human reductase for improved P450 function.
  • To present an integrated approach combining yeast expression and computer simulations for studying complex metabolic events, such as benzo[a]pyrene metabolism.

Related Experiment Videos

Main Methods:

  • Genomic engineering to achieve targeted modifications in yeast.
  • Overexpression of yeast NADPH-P450 reductase and co-expression of human cytochrome b5 and epoxide hydrolase.
  • Substitution of yeast reductase with human reductase via genome engineering and optimization of induction procedures.

Main Results:

  • Achieved significant improvements, up to 1000-fold, in yeast-expressed P450 activities.
  • Developed a third-generation yeast system with optimized induction for high P450 specific content.
  • Established a complementary approach using yeast expression and computer simulations for in-depth metabolic analysis.

Conclusions:

  • The progression of yeast expression systems has dramatically enhanced the utility of P450 enzymes in biotechnological applications.
  • The third-generation system, incorporating human reductase and optimized induction, represents a major leap in P450 activity.
  • The combined strategy of advanced yeast expression and computational modeling offers powerful insights into intricate metabolic pathways and pollutant degradation.